Single rapamycin administration induces prolonged downward shift in defended body weight in rats.
Manipulation of body weight set point may be an effective weight loss and maintenance strategy as the homeostatic mechanism governing energy balance remains intact even in obese conditions and counters the effort to lose weight. However, how the set point is determined is not well understood. We sho...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4008417?pdf=render |
| _version_ | 1818270892134760448 |
|---|---|
| author | Mark Hebert Maria Licursi Brittany Jensen Ashley Baker Steve Milway Charles Malsbury Virginia L Grant Robert Adamec Michiru Hirasawa Jacqueline Blundell |
| author_facet | Mark Hebert Maria Licursi Brittany Jensen Ashley Baker Steve Milway Charles Malsbury Virginia L Grant Robert Adamec Michiru Hirasawa Jacqueline Blundell |
| author_sort | Mark Hebert |
| collection | DOAJ |
| description | Manipulation of body weight set point may be an effective weight loss and maintenance strategy as the homeostatic mechanism governing energy balance remains intact even in obese conditions and counters the effort to lose weight. However, how the set point is determined is not well understood. We show that a single injection of rapamycin (RAP), an mTOR inhibitor, is sufficient to shift the set point in rats. Intraperitoneal RAP decreased food intake and daily weight gain for several days, but surprisingly, there was also a long-term reduction in body weight which lasted at least 10 weeks without additional RAP injection. These effects were not due to malaise or glucose intolerance. Two RAP administrations with a two-week interval had additive effects on body weight without desensitization and significantly reduced the white adipose tissue weight. When challenged with food deprivation, vehicle and RAP-treated rats responded with rebound hyperphagia, suggesting that RAP was not inhibiting compensatory responses to weight loss. Instead, RAP animals defended a lower body weight achieved after RAP treatment. Decreased food intake and body weight were also seen with intracerebroventricular injection of RAP, indicating that the RAP effect is at least partially mediated by the brain. In summary, we found a novel effect of RAP that maintains lower body weight by shifting the set point long-term. Thus, RAP and related compounds may be unique tools to investigate the mechanisms by which the defended level of body weight is determined; such compounds may also be used to complement weight loss strategy. |
| first_indexed | 2024-12-12T21:17:30Z |
| format | Article |
| id | doaj.art-be4be1b46b914ca993e913999a2d3912 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-12T21:17:30Z |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-be4be1b46b914ca993e913999a2d39122022-12-22T00:11:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0195e9369110.1371/journal.pone.0093691Single rapamycin administration induces prolonged downward shift in defended body weight in rats.Mark HebertMaria LicursiBrittany JensenAshley BakerSteve MilwayCharles MalsburyVirginia L GrantRobert AdamecMichiru HirasawaJacqueline BlundellManipulation of body weight set point may be an effective weight loss and maintenance strategy as the homeostatic mechanism governing energy balance remains intact even in obese conditions and counters the effort to lose weight. However, how the set point is determined is not well understood. We show that a single injection of rapamycin (RAP), an mTOR inhibitor, is sufficient to shift the set point in rats. Intraperitoneal RAP decreased food intake and daily weight gain for several days, but surprisingly, there was also a long-term reduction in body weight which lasted at least 10 weeks without additional RAP injection. These effects were not due to malaise or glucose intolerance. Two RAP administrations with a two-week interval had additive effects on body weight without desensitization and significantly reduced the white adipose tissue weight. When challenged with food deprivation, vehicle and RAP-treated rats responded with rebound hyperphagia, suggesting that RAP was not inhibiting compensatory responses to weight loss. Instead, RAP animals defended a lower body weight achieved after RAP treatment. Decreased food intake and body weight were also seen with intracerebroventricular injection of RAP, indicating that the RAP effect is at least partially mediated by the brain. In summary, we found a novel effect of RAP that maintains lower body weight by shifting the set point long-term. Thus, RAP and related compounds may be unique tools to investigate the mechanisms by which the defended level of body weight is determined; such compounds may also be used to complement weight loss strategy.http://europepmc.org/articles/PMC4008417?pdf=render |
| spellingShingle | Mark Hebert Maria Licursi Brittany Jensen Ashley Baker Steve Milway Charles Malsbury Virginia L Grant Robert Adamec Michiru Hirasawa Jacqueline Blundell Single rapamycin administration induces prolonged downward shift in defended body weight in rats. PLoS ONE |
| title | Single rapamycin administration induces prolonged downward shift in defended body weight in rats. |
| title_full | Single rapamycin administration induces prolonged downward shift in defended body weight in rats. |
| title_fullStr | Single rapamycin administration induces prolonged downward shift in defended body weight in rats. |
| title_full_unstemmed | Single rapamycin administration induces prolonged downward shift in defended body weight in rats. |
| title_short | Single rapamycin administration induces prolonged downward shift in defended body weight in rats. |
| title_sort | single rapamycin administration induces prolonged downward shift in defended body weight in rats |
| url | http://europepmc.org/articles/PMC4008417?pdf=render |
| work_keys_str_mv | AT markhebert singlerapamycinadministrationinducesprolongeddownwardshiftindefendedbodyweightinrats AT marialicursi singlerapamycinadministrationinducesprolongeddownwardshiftindefendedbodyweightinrats AT brittanyjensen singlerapamycinadministrationinducesprolongeddownwardshiftindefendedbodyweightinrats AT ashleybaker singlerapamycinadministrationinducesprolongeddownwardshiftindefendedbodyweightinrats AT stevemilway singlerapamycinadministrationinducesprolongeddownwardshiftindefendedbodyweightinrats AT charlesmalsbury singlerapamycinadministrationinducesprolongeddownwardshiftindefendedbodyweightinrats AT virginialgrant singlerapamycinadministrationinducesprolongeddownwardshiftindefendedbodyweightinrats AT robertadamec singlerapamycinadministrationinducesprolongeddownwardshiftindefendedbodyweightinrats AT michiruhirasawa singlerapamycinadministrationinducesprolongeddownwardshiftindefendedbodyweightinrats AT jacquelineblundell singlerapamycinadministrationinducesprolongeddownwardshiftindefendedbodyweightinrats |